Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Statement re Possible Offer

3 Sep 2020 10:46

RNS Number : 9617X
Honeycomb Investment Trust PLC
03 September 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE UK CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

3 September 2020

 

For immediate release

 

Announcement Regarding a Possible Combination of Honeycomb Investment Trust plc ("HIT") and Pollen Street Secured Lending plc ("PSSL")

 

Further to the recent announcements made in relation to a potential combination of HIT and PSSL, the board of HIT confirms it does not intend to make an offer under Rule 2.7 of the Code.

 

For the purposes of Rule 2.8 of the Code, HIT, and any person(s) acting in concert with it, reserve the right to make or participate in an offer or possible offer for PSSL (and/or take any other action which would otherwise be restricted under Rule 2.8 of the Code) within 6 months of the date of this announcement:

 

a. with the agreement of the board of directors of PSSL;

b. following the announcement of a firm intention to make an offer for PSSL by or on behalf of a third party;

c. following the announcement by PSSL of a proposal for a "whitewash" (as referred to in Note 1 of the Notes on Dispensations from Rule 9 of the Code) or for a reverse takeover (as defined in the Code); or

d. where the Panel on Takeovers and Mergers has determined that there has been a material change of circumstances.

 

The person responsible for arranging for the release of this announcement on behalf of HIT is Robert Sharpe, Chairman of HIT.

 

Enquiries:

 

Greenbrook (PR adviser to HIT) +44 (0) 207 952 2000

Andrew Honnor honeycomb@greenbrookpr.com

Alex Jones

Matthew Goodman

 

Goldman Sachs International (Joint Financial Adviser to HIT) +44 (0) 207 774 1000

John Brennan

Chris Emmerson

Ken Hayahara

Ronan Breen

 

Jefferies International Limited (Joint Financial Adviser to HIT) +44 (0) 207 029 8000

Graham Davidson +44 (0) 207 029 8076

Paul Bundred +44 (0) 207 548 4226Neil Winward +44 (0) 207 029 8140

 

 

Important Notices

 

A copy of this announcement will be available on HIT's website at https://www.honeycombplc.com/announcements. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

This announcement is not intended to, and does not, constitute, represent or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities whether pursuant to this announcement or otherwise.

 

The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law or regulation and therefore any person who comes into possession of this announcement should inform themselves about, and comply with, such restrictions. Any failure to comply with such restrictions may constitute a violation of the securities laws or regulations of any such relevant jurisdiction.

 

Goldman Sachs International, which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the PRA and the Financial Conduct Authority ("FCA") in the United Kingdom, is acting exclusively for HIT and for no one else in connection with the possible offer and will not be responsible to anyone other than HIT for providing the protections afforded to its clients or for providing advice in relation to the possible offer, the contents of this announcement or any other matters referred to in this announcement.

 

Jefferies which is authorised and regulated in the UK by the FCA, is acting exclusively as financial adviser to HIT and no one else in connection with the possible offer and shall not be responsible to anyone other than HIT for providing the protections afforded to clients of Jefferies nor for providing advice in connection with the possible offer or any matter referred to herein. Neither Jefferies, nor any of its affiliates, subsidiaries or branches owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person other than HIT in connection with this announcement, any statement contained herein or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDGCGDCXSGDGGX
Date   Source Headline
27th Jan 20206:26 pmRNSResult of Buy-Back and total voting rights
27th Jan 20204:08 pmRNSProposed Share Trade and Share Buy-Back
23rd Jan 20207:01 amRNSMonthly Update - December 2019
23rd Jan 20207:00 amRNSNet Asset Value(s)
20th Dec 20197:01 amRNSMonthly Update - November 2019
20th Dec 20197:00 amRNSNet Asset Value(s)
16th Dec 20191:51 pmRNSResult of General Meeting
29th Nov 20197:00 amRNSCircular and Notice of General Meeting
27th Nov 20197:01 amRNSMonthly Update - October 2019
27th Nov 20197:00 amRNSNet Asset Value(s)
19th Nov 20194:13 pmRNSHolding(s) in Company
8th Nov 20197:00 amRNSDividend Declaration
21st Oct 20197:01 amRNSMonthly Update - September 2019
21st Oct 20197:00 amRNSNet Asset Value(s)
30th Sep 20197:01 amRNSMonthly Update - August 2019
30th Sep 20197:00 amRNSNet Asset Value(s)
10th Sep 20197:00 amRNSHalf-year Report 2019
5th Sep 20193:02 pmRNSDividend Declaration
21st Aug 20197:01 amRNSMonthly Update - July 2019
21st Aug 20197:00 amRNSNet Asset Value(s)
12th Aug 20192:51 pmRNSPublication of Suppl.Prospcts
7th Aug 20195:13 pmRNSDirector/PDMR Shareholding
25th Jul 20197:01 amRNSMonthly Update - June 2019
25th Jul 20197:00 amRNSNet Asset Value(s)
25th Jun 201910:10 amRNSMonthly Update - 31 May 2019
25th Jun 201910:04 amRNSNet Asset Value(s)
14th Jun 20197:00 amRNSDirectorate Change
6th Jun 20195:33 pmRNSResult of AGM
21st May 20197:01 amRNSMonthly Update - 30 April 2019
21st May 20197:00 amRNSNet Asset Value(s)
3rd May 20192:46 pmRNSNotice of Annual Report & Director Resignation
29th Apr 20197:00 amRNSDividend Declaration
29th Apr 20197:00 amRNSAnnual Report and Audited Financial Statements
26th Apr 20197:01 amRNSMonthly Update - 31 March 2019
26th Apr 20197:00 amRNSNet Asset Value(s)
21st Mar 20197:01 amRNSMonthly Update - 28 February 2019
21st Mar 20197:00 amRNSNet Asset Value(s)
22nd Feb 20197:02 amRNSMonthly Update - 31 January 2019
22nd Feb 20197:01 amRNSDividend Declaration
22nd Feb 20197:00 amRNSNet Asset Value(s)
29th Jan 20197:01 amRNSFact Sheet December 2018
29th Jan 20197:00 amRNSNet Asset Value(s)
21st Dec 201812:49 pmRNSPlacing Programme: publication of prospectus
21st Dec 20187:01 amRNSMonthly Update - 30 November 2018
21st Dec 20187:00 amRNSNet Asset Value - 30 November 2018
22nd Nov 20187:01 amRNSMonthly Update - 31 October 2018
22nd Nov 20187:00 amRNSNet Asset Value - 31 October 2018
16th Nov 20187:00 amRNSDividend Declaration
23rd Oct 20187:01 amRNSMonthly Update - 30 September 2018
23rd Oct 20187:00 amRNSNet Asset Value - 30 September 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.